Synthera | AI-Powered Drug Discovery

🔬 Core Capabilities

Molecule Generation
Design novel compounds using AI-powered generative models.

Binding Affinity Prediction
Evaluate how tightly a drug binds to its target protein.

QSAR Analysis
Quantitative structure–activity relationship modeling for predictive insight.

Toxicity Prediction
Screen compounds for toxicity using deep learning models.

Druglikeness Scoring
Assess pharmacological suitability with AI-based scoring systems.

ADME Profiling
Analyze Absorption, Distribution, Metabolism, and Excretion properties.

Bioavailability Estimation
Model how much and how fast a compound reaches systemic circulation.

Protein-Protein Interaction (PPI)
Visualize and predict PPI disruptions for therapeutic targeting.

🧠 How Synthera Works

Synthera is an AI-native drug discovery platform that uses multimodal machine learning to accelerate therapeutic innovation.

Our platform supports:

- Generative AI (VAE + GNNs) for molecule design

- Transformer-based models for protein target analysis

- ADME-tox modeling using structured and unstructured data

- Real-time docking predictions for target-ligand interaction

- Scalable architecture hosted on Microsoft Azure for global deployment

Whether you're a researcher, biopharma innovator, or startup, Synthera empowers your discovery pipeline with powerful tools in a single platform.